SE0103046D0 - Kristallin bas av citalopram - Google Patents

Kristallin bas av citalopram

Info

Publication number
SE0103046D0
SE0103046D0 SE0103046A SE0103046A SE0103046D0 SE 0103046 D0 SE0103046 D0 SE 0103046D0 SE 0103046 A SE0103046 A SE 0103046A SE 0103046 A SE0103046 A SE 0103046A SE 0103046 D0 SE0103046 D0 SE 0103046D0
Authority
SE
Sweden
Prior art keywords
citalopram
base
salt
crystalline
precipitation
Prior art date
Application number
SE0103046A
Other languages
English (en)
Other versions
SE517136C2 (sv
SE0103046L (sv
Inventor
Hans Petersen
Klaus Peter Boegesoe
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0103046(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SE0103046D0 publication Critical patent/SE0103046D0/sv
Publication of SE0103046L publication Critical patent/SE0103046L/sv
Publication of SE517136C2 publication Critical patent/SE517136C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Laminated Bodies (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
SE0103046A 2000-03-13 2001-09-14 Kristallin bas av citalopram SE517136C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000402 2000-03-13
DKPCT/DK00/00183 2000-04-13
PCT/DK2001/000137 WO2001068627A1 (en) 2000-03-13 2001-02-28 Crystalline base of citalopram

Publications (3)

Publication Number Publication Date
SE0103046D0 true SE0103046D0 (sv) 2001-09-14
SE0103046L SE0103046L (sv) 2001-11-14
SE517136C2 SE517136C2 (sv) 2002-04-16

Family

ID=8159320

Family Applications (2)

Application Number Title Priority Date Filing Date
SE0103046A SE517136C2 (sv) 2000-03-13 2001-09-14 Kristallin bas av citalopram
SE0200730A SE526022C2 (sv) 2000-03-13 2002-03-12 Kristallin bas av citalopram

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE0200730A SE526022C2 (sv) 2000-03-13 2002-03-12 Kristallin bas av citalopram

Country Status (42)

Country Link
US (7) US20010031784A1 (sv)
EP (2) EP1227088B1 (sv)
JP (1) JP2003527383A (sv)
KR (1) KR20020080486A (sv)
CN (2) CN1680350A (sv)
AR (1) AR029811A1 (sv)
AT (3) ATE250050T1 (sv)
AU (2) AU746664B2 (sv)
BE (1) BE1013210A3 (sv)
BG (1) BG107065A (sv)
BR (1) BR0109373A (sv)
CA (2) CA2360287C (sv)
CH (2) CH691477A5 (sv)
CZ (1) CZ292077B6 (sv)
DE (7) DE20007303U1 (sv)
DK (3) DK173903B1 (sv)
EA (1) EA200200972A1 (sv)
ES (3) ES2173054T3 (sv)
FI (2) FI20010156A0 (sv)
FR (1) FR2806086B1 (sv)
GB (2) GB2357762B (sv)
GR (1) GR1003796B (sv)
HK (1) HK1054750A1 (sv)
HR (1) HRP20020756A2 (sv)
HU (3) HU0001581D0 (sv)
IE (1) IES20010109A2 (sv)
IL (2) IL147339A (sv)
IS (1) IS5841A (sv)
IT (2) IT1319645B1 (sv)
MX (1) MXPA02008793A (sv)
NL (2) NL1016435C1 (sv)
NO (2) NO312031B1 (sv)
PL (1) PL360158A1 (sv)
PT (2) PT1227088E (sv)
SE (2) SE517136C2 (sv)
SI (2) SI1227088T1 (sv)
SK (1) SK285528B6 (sv)
TR (1) TR200202185T2 (sv)
UA (1) UA74360C2 (sv)
WO (1) WO2001068627A1 (sv)
YU (1) YU68802A (sv)
ZA (1) ZA200207148B (sv)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE237604T1 (de) * 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7887556B2 (en) 2000-12-20 2011-02-15 Fox Hollow Technologies, Inc. Debulking catheters and methods
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
GB2376233B (en) * 2000-08-10 2003-09-10 Lundbeck & Co As H Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
ES2436668T3 (es) 2000-12-20 2014-01-03 Covidien Lp Catéter para retirar material oclusivo ateromatoso o trombótico
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure cithalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
IL158031A0 (en) * 2001-05-01 2004-03-28 Lundbeck & Co As H The use of enantiomeric pure escitalopram
DE60217932T2 (de) 2001-07-31 2007-08-30 H. Lundbeck A/S, Valby Kristalline Zusammensetzung enthaltend Escitalopram
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
GB2386118A (en) * 2002-02-27 2003-09-10 Cipla Ltd Citalopram
GB0204607D0 (en) 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2387596B (en) * 2002-02-27 2004-02-11 Matrix Lab Ltd Process
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
AU2003238676A1 (en) * 2003-04-21 2004-11-19 Podile Khadgapathi An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
GB0317475D0 (en) * 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
JP4025735B2 (ja) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー 水性系を処理する方法
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
CN100569765C (zh) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
ITTO20050301A1 (it) * 2005-05-05 2006-11-06 Errekappa Euroterapici Spa Formulazioni liquide orali contenenti citalopram
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2502621A1 (en) 2005-06-27 2012-09-26 Valeant International (Barbados) SRL Crystalline forms of bupropion HBr
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
US8414604B2 (en) 2008-10-13 2013-04-09 Covidien Lp Devices and methods for manipulating a catheter shaft
BRPI1014721A2 (pt) 2009-04-29 2016-04-12 Tyco Healthcare métodos e dispositivos para cortar e raspar tecido
JP5281195B2 (ja) 2009-05-14 2013-09-04 コヴィディエン リミテッド パートナーシップ 簡単に清掃され得るアテレクトミー用カテーテルおよび使用の方法
KR20120079479A (ko) 2009-12-02 2012-07-12 타이코 헬스케어 그룹 엘피 조직 절단 장치 및 방법
US20110144673A1 (en) 2009-12-11 2011-06-16 Fox Hollow Technologies, Inc. Material removal device having improved material capture efficiency and methods of use
EP2742881B1 (en) 2010-06-14 2015-10-07 Covidien LP Material removal device
US8920450B2 (en) 2010-10-28 2014-12-30 Covidien Lp Material removal device and method of use
KR101518151B1 (ko) 2010-11-11 2015-05-06 코비디엔 엘피 촬영용 가요성 디벌킹 카테터와, 사용 및 제조 방법
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2233970A (en) * 1941-03-04 Quinoline compound and process of
US2584429A (en) * 1950-12-29 1952-02-05 Rohm & Haas 1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143702A (sv) * 1965-03-18
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
JP3526581B2 (ja) * 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CZ292911B6 (cs) * 1997-11-11 2004-01-14 H. Lundbeck A/S Způsob výroby citalopramu
PL199423B1 (pl) 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
HK1054750A1 (en) 2003-12-12
HUP0100531A3 (en) 2004-04-28
EP1169314B1 (en) 2002-09-04
ITMI20010406A1 (it) 2002-08-28
CA2360287A1 (en) 2001-09-20
US20040132808A1 (en) 2004-07-08
GB2357762A (en) 2001-07-04
NO315851B1 (no) 2003-11-03
TR200202185T2 (tr) 2002-12-23
CA2411732A1 (en) 2001-09-20
US20040167210A1 (en) 2004-08-26
IL147339A0 (en) 2002-08-14
US20050165244A1 (en) 2005-07-28
EP1169314B2 (en) 2011-06-01
NO312031B1 (no) 2002-03-04
US20010031784A1 (en) 2001-10-18
US20030078442A1 (en) 2003-04-24
AR029811A1 (es) 2003-07-16
DE60100022T3 (de) 2011-11-17
SI1227088T1 (en) 2003-12-31
EP1169314A1 (en) 2002-01-09
SE526022C2 (sv) 2005-06-14
FI109022B (sv) 2002-05-15
CN1429220A (zh) 2003-07-09
HU0100450D0 (en) 2001-04-28
MXPA02008793A (es) 2003-02-12
ATE250050T1 (de) 2003-10-15
DK1169314T3 (da) 2002-10-14
BR0109373A (pt) 2002-12-24
AU2001100197B4 (en) 2001-12-06
HUP0100531A2 (hu) 2002-01-28
DE10108042A1 (de) 2001-10-18
YU68802A (sh) 2005-11-28
NO20020356D0 (no) 2002-01-23
GB0105982D0 (en) 2001-05-02
NO20010619D0 (no) 2001-02-06
ES2173054T1 (es) 2002-10-16
SI1169314T1 (en) 2002-12-31
SE517136C2 (sv) 2002-04-16
UA74360C2 (uk) 2005-12-15
US20050165092A1 (en) 2005-07-28
DE10164687B4 (de) 2006-04-27
KR20020080486A (ko) 2002-10-23
HU0100531D0 (en) 2001-03-28
IES20010109A2 (en) 2002-02-20
CN1258530C (zh) 2006-06-07
ATE223396T1 (de) 2002-09-15
ES2173054T3 (es) 2002-12-16
NO20020356L (no) 2001-09-14
HU0001581D0 (en) 2000-06-28
WO2001068627A1 (en) 2001-09-20
GB2357762B (en) 2002-01-30
HRP20020756A2 (en) 2004-12-31
DK1227088T3 (da) 2003-12-22
DE60100786D1 (de) 2003-10-23
US20060247451A1 (en) 2006-11-02
IT1319645B1 (it) 2003-10-23
DE60100022T2 (de) 2003-03-06
CH691477A5 (de) 2001-07-31
CH691537A5 (de) 2001-08-15
FI20010156A0 (sv) 2001-01-25
SE0103046L (sv) 2001-11-14
ES2159491A1 (es) 2001-10-01
DE60100786T2 (de) 2004-07-15
SE0200730D0 (sv) 2002-03-12
FR2806086B1 (fr) 2003-05-09
NO20010619L (no) 2001-09-14
DE1227088T1 (de) 2003-02-06
SK285528B6 (sk) 2007-03-01
DE20121240U1 (de) 2002-07-04
AU746664B2 (en) 2002-05-02
PT1227088E (pt) 2003-12-31
NL1017413C1 (nl) 2001-09-13
AU2001100197A4 (en) 2001-09-20
SI1169314T2 (sl) 2011-08-31
FR2806086A1 (fr) 2001-09-14
FI20010225A (sv) 2001-09-14
ES2159491B1 (es) 2002-05-01
BG107065A (bg) 2003-05-30
ES2180471T1 (es) 2003-02-16
NL1016435C1 (nl) 2000-11-06
BE1013210A3 (fr) 2001-10-02
EA200200972A1 (ru) 2003-02-27
PT1169314E (pt) 2002-11-29
ZA200207148B (en) 2003-04-23
EP1227088B1 (en) 2003-09-17
SK13132002A3 (sk) 2003-01-09
GR1003796B (el) 2002-02-08
DE60100022D1 (de) 2002-10-10
IS5841A (is) 2001-09-14
IL158072A0 (en) 2004-03-28
CZ292077B6 (cs) 2003-07-16
CN1680350A (zh) 2005-10-12
AU3725201A (en) 2001-09-13
PL360158A1 (en) 2004-09-06
AT4364U1 (de) 2001-06-25
FI20010225A0 (sv) 2001-02-07
JP2003527383A (ja) 2003-09-16
CA2360287C (en) 2003-09-09
DE20007303U1 (de) 2000-07-27
SE0200730L (sv) 2002-08-29
IL147339A (en) 2004-09-27
GB0102797D0 (en) 2001-03-21
DK173903B1 (da) 2002-02-11
EP1227088A1 (en) 2002-07-31
ITMI20002425A1 (it) 2002-05-09
ES2180471T3 (es) 2004-05-01
CZ2001808A3 (cs) 2002-01-16

Similar Documents

Publication Publication Date Title
SE0200730L (sv) Kristallin bas av citalopram
TW200612195A (en) Oxime derivatives and the use therof as latent acids
SI2428519T1 (sl) Sestavek za pripravo 17-vinil-triflatov kot intermediatov
AR056762A1 (es) (4 -(6-halo-7- substituidos -2,4- dioxo-1,4- dihidro-2h-quinazolin-3-il- fenil)-5- cloro- tiophen-2- il sulfonilureas y formas y metodos
HK1076107A1 (en) Pyrrolidine derivatives as oxytocin antagonists
HRP20050424A2 (en) Process for making risperidone and intermediates thereof
ATE332304T1 (de) Cefdinir salze als zwischenprodukte
NO20002589D0 (no) Bifenylamidinderivater
AR027559A1 (es) Metodo para la preparacion de citalopram
AR037005A1 (es) Derivados de acidos dimetilfenilaceticos, derivados de piperidina, y proceso para la produccion de derivados de piperidina.
ATE257832T1 (de) Verfahren zur herstellung von citalopram
AR029893A1 (es) Metodo para la preparacion de citalopram, intermediarios y composicion farmaceutica
NO330965B1 (no) Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt
NO20032314D0 (no) Nye desloratadinsalter, fremgangsmåte for deres syntese og farmasöytiske preparater derav
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.
DE602004015310D1 (de) Verfahren zur herstellung von mycophenolatmofetil
YU34303A (sh) Postupak za proizvodnju 4-(17alfa-supstituisani-3-oksoestra -4,9-dien-11beta-il)benzaldehid-(1e ili 1z)-oksima
DK0846111T3 (da) Syntese af optisk rene forbindelser, der er anvendelige som GARFT-inhibitorer, og deres mellemprodukter
PT1423385E (pt) Intermediários para preparar conjugados inibidores da neuraminidase
AR036680A1 (es) Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion
MY142362A (en) Pharmaceutical composition for promoting angiogenesis
ATE359990T1 (de) Verfahren zur herstellung von 3,5- bisalkylphenolen
TR200402333T4 (tr) Artropodisidal karboksanilidler
HU0201584D0 (sv)
HUP0001753A2 (hu) Új eljárás (+/-)-3-(3,4-diklór-fenil)-2-dimetil-amino-2-metil-propán-1-ol vagy cericlamin (INN) előállítására és intermedierjei

Legal Events

Date Code Title Description
NUG Patent has lapsed